Potential cardioprotective effect of trimetazidine in mice model of endotoxemia: role of AMPK-Nrf2

  • Wiad Lek. 2025;78(1):35-44. doi: 10.36740/WLek/190820.
Alaa Kadhum Mosa  1 ,  Sahar Majeed  1 ,  Fadhaa Abdulameer Ghafil  1 ,  Najah Rayish Hadi  1
Affiliations
  • 1. PHARMACOLOGY AND THERAPEUTIC DEPARTMENT, FACULTY OF MEDICINE, UNIVERSITY OF KUFA, KUFA, IRAQ.
PMID: 40023854 DOI: 10.36740/WLek/190820
Abstract

Objective: Aim: To clarify the potential cardioprotective effect of Trimetazidine against experimentally sepsis-caused endotoxic cardiac injury damage in mice.

Patients and methods: Materials and Methods: 24 Mice were divided into four groups (n=6): Sham group, CLP group DMSO group, trimetazidine-treated group 50 mg/kg IP, 1hr before CLP, then the Animals were sacrificed 24 hr after CLP and tissue sample was taken for measurement of TNF-α, TNF-αr1, IL-1β, HO-1, MPO, caspase-11, F2-isoprostane and serum troponin by ELISA and gene expression of AMPK-Nrf2 by qpcr and histopathological study.

Results: Results: trimetazidine treated group showed significant changes as compared with clp group regarding TNF-α, TNF-αr1, IL-1β, HO-1, MPO, CASPASE-11, F2-ISOPROSTANE as well as affect tissue mRNA expression of AMPK-Nrf2 genes p<0.05.

Conclusion: Conclusions: We evaluate that Trimetazidine has cardio protective effects due to its anti-inflammatory and anti-oxidative action. Also, trimetazidine showed a cardio-protective effect as they affect tissue mRNA expression of AMPK-Nrf2 genes.

Keywords
CLP; TNF-α; sepsis; trimetazidine; F2-isoprostane; Ho-1, MPO; IL-1β; caspase-11; TNF-αr1.
Products